Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urine-based nematode chemotaxis assay (N-NOSE) as a predictor of recurrence after curative surgery for resectable pancreatic cancer: preliminary data and single center experience.

BMC surgery·2025
Same author

Beyond Binary: A Machine Learning Framework for Interpreting Organismal Behavior in Cancer Diagnostics.

Biomedicines·2025
Same author

The Convergent Frontier: Integrating Molecular, Computational, and Surgical Sciences in Oncology.

Biomedicines·2025
Same author

Application of N-NOSE for Evaluating the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.

Cells·2025
Same author

In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines.

International journal of molecular sciences·2025
Same author

Detection of Hematological Malignancies Using N-NOSE (Nematode-NOSE).

Hematological oncology·2025

Related Experiment Video

Updated: Aug 24, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.1K

C. elegans as a Powerful Tool for Cancer Screening.

Eric di Luccio1, Masayo Morishita1, Takaaki Hirotsu1

  • 1Hirotsu Bioscience Inc., 22F The New Otani Garden Court, 4-1 Kioicho Chiyoda-ku, Tokyo 102-0094, Japan.

Biomedicines
|October 27, 2022
PubMed
Summary

Multi-cancer early detection (MCED) using the nematode C. elegans offers a promising, less invasive screening method. The N-NOSE test, utilizing this biosensor, demonstrates high sensitivity and specificity for early cancer detection.

Keywords:
C. elegansN-NOSEmulti-cancer screeningolfactionprimary screeningurine

More Related Videos

Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform
07:20

Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform

Published on: November 28, 2018

9.2K
Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans
10:55

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans

Published on: February 22, 2015

8.2K

Related Experiment Videos

Last Updated: Aug 24, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.1K
Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform
07:20

Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform

Published on: November 28, 2018

9.2K
Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans
10:55

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans

Published on: February 22, 2015

8.2K

Area of Science:

  • Biomedical Science
  • Oncology
  • Biosensor Technology

Background:

  • Current cancer screening methods are often invasive, costly, and burdensome.
  • Effective early detection remains a significant challenge in healthcare.
  • Multi-cancer early detection (MCED) technologies offer a potential solution.

Purpose of the Study:

  • To review the application of Caenorhabditis elegans as a biosensor for universal cancer screening.
  • To evaluate the clinical efficacy of the N-NOSE test, an MCED utilizing C. elegans.

Main Methods:

  • Focus on the use of Caenorhabditis elegans chemotaxis in a urine-based assay.
  • Review of clinical research data for the N-NOSE multi-cancer detection test.
  • Analysis of sensitivity and specificity of the N-NOSE test.

Main Results:

  • C. elegans serves as a potent biosensor for detecting cancer signals.
  • The N-NOSE test demonstrated 87.5% sensitivity and 90.2% specificity in detecting multiple cancers.
  • The test is commercially available in Japan.

Conclusions:

  • C. elegans-based biosensors represent a novel approach to primary cancer screening.
  • The N-NOSE test is highlighted as an effective tool for early cancer detection.
  • MCED technologies like N-NOSE have the potential to improve cancer screening rates and effectiveness.